Clinical Trial Update: A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating a new drug for overactive bladder; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Snippet

Sponsor: Urovant Sciences GmbH | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2021-03-04